Patent · US Active

Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes

US7674888B2 · kind B2 · utility

4Cited by

25References

5Claims

0Family size

Assignee

BIOMERIEUX, INC. · FR

Inventors

Herve Perron · Val-de-Reuil, FR
Frederic Beseme · Villefontaine, FR
Frederic Bedin · Val-de-Reuil, FR
Glaucia Paranhos-Baccala · Val-de-Reuil, FR
Florence Komurian-Pradel · Caluire-et-Cuire, FR
Colette Jolivet-Reynaud · Genas, FR
Bernard Mandrand · Villeurbanne, FR
Jeremy Garson · Guildford, GB
Philip Tuke · London, GB

Key dates

Filing date	Oct 16, 2006
Grant date	Mar 9, 2010
Priority date	—
Expiry date	Jul 3, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/10051
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides viral material and nucleotide fragments associated with multiple sclerosis and/or rheumatoid arthritis for use in method of diagnosis, prophylaxis, and therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.